Poly(ADP-ribose) polymerase-1 (PARP1) is a ubiquitous nuclear enzyme that regulates DNA repair and genomic stability. In oxidative genotoxic conditions, PARP1 activity is enhanced significantly, leading to excessive depletion of nicotinamide adenine dinucleotide (NAD + ) and mitochondrial dysfunction. We hypothesized that PARP1-induced NAD + depletion inhibits 
Introduction
Inhibition or deletion of the nuclear enzyme, poly(ADP-ribose) polymerase (PARP)-1, produces striking neuroprotection across several models of neurological disease and injury (Eliasson et al., 1997; LaPlaca et al., 2001; Martire et al., 2015; Yu et al., 2002; Zhang et al., 1994) . Thus, PARP1 is an attractive target for mechanistic and therapeutic investigation in neurodegeneration. PARP1 catalyzes the transfer of ADP-ribose units from NAD + to form ADPribose polymers (PAR) on target proteins in response to DNA damage, post-translational modification, and various signal transduction pathways (Bai, 2015) . PARP1 activity influences chromatin structure and epigenetic control of transcription, and is important for DNA repair,
with PARylated genomic proteins serving as signalling platforms for DNA repair factors (De Vos et al., 2012) . These processes are normally important contributors to homeostasis; however, in the context of pathological oxidative stress accompanying disease or injury, extensive DNA damage leads to excessive PARP1 activity, significant depletion of cytosolic/nuclear NAD + stores and accumulation of free PAR. There is a constellation of downstream consequences related to PARP1-induced NAD + -depletion and PAR accumulation that is independent of NAD + .
In tissue affected by severe injury, PARP1-induced cell necrosis can occur due to NAD + -consumption and fatal purine nucleotide depletion  Cohen and Barankiewicz, NAD + -depletion inhibits the sirtuin deacetylase, SIRT1, which governs a wide range of mitochondrial functions (Cantó et al., 2013) , including release of AIF Lu et al., 2014) .
Sirtuins (SIRTs) 1-7 are class III histone deacetylases (HDACs) that require NAD + for catalytic activity and influence cell survival and longevity (Anderson et al., 2003; Howitz et al., 2003) . SIRT1 regulates transcription factors and co-activators that affect mitochondrial structure and function, including forkhead box O (FoxO) family members, hypoxia-inducible factor 1, and peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α). Reduced NAD + availability resulting from PARP1 activity inhibits SIRT1 (Bai et al., 2011; Lu et al., 2014) , and loss of SIRT1 activity is associated with reduced mitochondrial membrane potential, ATP depletion, initiation of pro-apoptotic pathways and neuronal death (Conrad et al., 2016; Lu et al., 2014; Price et al., 2012) . PGC-1α is a transcriptional co-activator that serves as a master regulator of mitochondrial function by controlling expression of nuclear-encoded mitochondrial proteins involved in mitochondrial biogenesis, structure and function (Mutikainen et al., 2016) .
PGC-1α regulates expression of nuclear respiratory factor (NRF)-1, for example (Mootha et al., 2004 ), which in turn governs expression of mitochondrial proteins involved in replication and transcription of mitochondrial DNA, including cytochrome-c and mitochondrial transcription factor A (TFAM) (Wu et al., 1999) . PGC-1α is subject to post-translational modification, including reversible lysine acetylation (Dominy et al., 2010) , and its transcriptional activity is closely associated with its acetylation state, which is tightly regulated by SIRT1 (Rodgers et al., 2005) .
Previously, we found that pathophysiological PARP1 activation led to NAD + depletion sufficient to inhibit SIRT1, increase FoxO3a transcriptional activity and increase neuron death dependent on the pro-death BH3-only Bcl-2 family protein, Bcl-2/adenovirus E1B 19 kDainteracting protein (Bnip3) (Lu et al., 2014) . Since SIRT1 is a central regulator of multiple pathways and gene targets that converge on mitochondrial function, the goal of the current study was to determine whether there is interplay between SIRT1 and PGC-1α in pathological PARP1
activation, resulting in transcriptional regulation of mitochondrial respiration. We hypothesized that PARP1-mediated NAD + depletion inhibits SIRT1, thereby causing PGC-1α hyperacetylation and altered transcription of genes that influence mitochondrial function and cell death.
Materials and Methods

Reagents and experimental animals.
N- (6-oxo-5,6-dihydrophenanthridin-2-yl) -N, N-dimethylacetamide HCl (PJ34) was purchased from Calbiochem. Protein inhibitor cocktail tablets and bicinchoninic acid (BCA) protein assay kits were from Roche Diagnostics and Thermo Scientific, respectively. N'-Nitro-N-nitroso-Nmethylguanidine (MNNG) was purchased from Toronto Research Chemicals Inc. All the other reagents were purchased from Sigma-Aldrich Canada, unless otherwise indicated. Parp1 -/-mice (129S-Parp1 tm1Zqw /J) were purchased from Jackson Laboratories and a homozygous colony was maintained in-house. CD-1 mouse embryos were used for the majority of experiments examining wild-type mice, but trends were verified in selected experiments using background the background 129S mice used to generate the Jackson parp1 -/-strain. Dams were housed singly with a 12-h light/dark cycle at 22 ± 1°C with ad libitum access to water, standard chow and environmental enrichment.
Mouse primary neuronal cultures and experimental treatments.
Primary neuron cultures were prepared from embryonic day 15-16 mouse cortices from either sex, as described previously Lu et al., 2014) . Dams were anesthetized with inhaled CO 2 and sacrificed by cervical dislocation in accordance with the guidelines of the Canadian Council on Animal Care. The University of Manitoba Protocol Management and Review Committee has attested to this compliance by approving our animal use protocol (14-033). Cells (3-6 biological replicates) were plated on poly-D-lysine-coated plates in Neurobasal medium (NB) with B27 supplement (Invitrogen), 1.2 mM glutamine, and 5% fetal bovine serum (FBS; Hyclone). FBS was removed the following day. Cytosine arabinofuranoside (2 µM) was added on day 2 to prevent glial proliferation and replaced on day 3 with NB/B27/glutamine.
Cultures were maintained at 37°C/5% CO 2 and given a partial media change on day 6. They were used on day 8-9 for all experiments. To activate PARP1, cortical neurons were exposed to a DNA alkylating agent, MNNG (50 µM, 30 min) and then rescued in NB medium for 4-24 h.
Media was changed after MNNG exposure. NAD + (3 mM) was added immediately after medium exchange, while PJ34 (10 µM) was added 30 min before the addition of MNNG. PJ34 was also added again after the medium exchange. Cell viability was assessed using the Cell Counting Kit-8 (Wako Pure Chemicals), which is based on colorimetric reduction of soluble 2-(2-methoxy-4-
activity. Cells were incubated with 10 µl WST-8 solution in a 96-well plate for 2 hr at 37°C.
Absorbance of the yellow formazan dye product was assessed at 450 nm using a plate-reading spectrophotometer.
NAD + determinations.
Intracellular NAD + levels were assessed as previously described (Lu et al., 2014) . Briefly, neuronal extractions were performed using perchloric acid, and NAD + was measured using high performance liquid chromatography through a Supelcosil TM LC18-T HPLC column (4.6×250 mm column, 5 µm particle size, 100 Å pore size) at a flow rate of 0.5 ml/min through a photodiode array detector. NAD + levels were normalized to protein content of the samples as determined by the BCA method.
SIRT activity assay.
SIRT activity was determined in live neurons in situ, using the SIRT1 Direct Fluorescent
Screening Assay Kit (Cayman Chemical Company). Neurons were plated on 96-well plates at 6 × 10 4 cells/well and equilibrated with 25 µl of assay buffer (50 mM Tris-HCl, 137 mM NaCl, 2.7 mM KCl, and 1mM MgCl 2 , pH8.0). Substrate solution (15 µl), containing the p53 deacetylation target sequence Arg-His-Lys-Lys(ɛ-acetyl)-aminomethylcoumarin and the HDAC I/II inhibitor trichostatin A, was added on a shaker for 45 min. Relative sample fluorescence was determined using a 96-well format fluorometer with an excitation wavelength of 355 nm and an emission wavelength of 460 nm.
Mitochondrial (mt)DNA analysis.
Genomic DNA was extracted with phenol and chloroform, precipitated using ethanol, and resuspended in sterile water. The mtDNA gene encoding cytochrome c oxidase subunit I (CO1), and the nuclear NDUFV1 gene (nDNA) were amplified using iTaq™ Universal SYBR ® Green
Supermix (Bio-Rad) in a quantitative PCR protocol (ABI 7300 Fast Real-Time PCR System).
The CO1 primers were 5'-TGC TAG CCG CAG GCATTA C-3' (forward primer) and 5'-GGG TGC CCA AAG AAT CAG AAC-3' (reverse primer). The NDUFV1 primers were 5'-CTTCCCCACTGGCCTCAA G-3' (forward primer) and 5'-CCA AAA CCC AGT GAT CCA GC-3' (reverse primer) (Amthor et al., 2007) . Genomic DNA (2 µl, 40 ng/ml) was used for PCR amplification. PCR was performed as follows: 95 °C for 15 min, 40 cycles (95 °C for 15 s; 60 °C for 30 s). Amplification curves were analyzed using SDS 1.9.1 software (Applied Biosystems), and these curves were used to determine relative mtDNA:nDNA ratios. Specificity was verified by melt curve analysis.
Mitochondrial mass measurement.
For mitochondrial mass measurements, cultured primary neurons were loaded with mitotrackerred (Invitrogen) at a final concentration of 500 nM and incubated for 20 min at 37°C. Cells were lysed in lysis buffer (25 mM Tris-HCl, 150 mM NaCl, and 1% Triton X-100, 2mM Na 3 VO 4 , 1 mM PMSF, with protease inhibitor cocktail, pH 8.0). Equal amounts from each sample lysate were analyzed in a microplate reader (excitation and emission 570 and 590 nm, respectively, Biotek) to quantify fluorescence intensity. Mitotracker-red fluorescence intensity values were normalized to total the protein content of each well. The data is presented as percent change relative to control levels.
Lentiviral shRNA treatment of neuron cultures.
A short hairpin RNA (shRNA) construct for CD38 (TRCN0000068230) was obtained from Open Biosystems (now GE Healthcare) in the pLKO.1 plasmid backbone. A scrambled control construct was purchased from Addgene (plasmid #1864). High-titer lentiviral preparations expressing shRNA and control sequences were prepared by the Lentiviral Core Platform of the University of Manitoba. Neurons were infected at 1 d in vitro (DIV) with a multiplicity of infection (MOI) of 1 in the presence of 1 µg/ml polybrene for 6 h. Medium was replaced with fresh neurobasal medium. CD38 silencing was confirmed by real-time PCR and Western blotting at 7 DIV.
Real-time PCR.
Total RNA was extracted using the RNeasy Kit (Qiagen). Real-time RT-PCR was performed using an iScript One-Step RTPCR Kit with SYBR Green (Bio-Rad) and a Bio-Rad iCycler.
Primers for mouse TFAM and β-actin are as follows: TFAM forward: 5'-GTAGAACTGCACTTCAGCAATGG-3'; TFAM reverse: 5'-GGGCTGTCACAGTGAGAACTC-3'; β-actin forward: 5'-GGGCTATGCTCTCCCTCACG-3';
and β-actin reverse: 5'-GTCACGCACGATTTCCCTCTC-3'. PCR parameters were as follows:
50°C for 10 min, 95°C for 5 min, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s.
Standard curves were generated, and the relative amount of target gene mRNA was normalized to β-actin. Specificity was verified by melt curve analysis. 
Chromatin immunoprecipitation.
Chromatin immunoprecipitation (ChIP) assays were performed as described using a kit and the manufacturer's protocol (Cell Signaling Technology) with a few modifications (Mammucari et al., 2007) . Briefly, cells (5 × 10 6 ) were cross-linked with 1% formaldehyde at room temperature for 10 min, rinsed twice with PBS, and harvested in 1 ml of hypotonic buffer (15mM Tris-HCl, 60mM KCl, 15mM NaCl, 5mM MgCl 2 , 1 mM CaCl 2 , 2 mM Na 3 VO 4 , 0.25 M sucrose, 1 mM PMSF, and 1 mM DTT, pH 7.5) with protease inhibitor mixture (Roche Applied Science). After 5 min on ice, an equal volume of hypotonic buffer with 0.6% NP-40 was added for an additional 5 min period, and the mixture was centrifuged at 2,500 × g for 2 min (4°C). Pelleted nuclei were digested by micrococcal nuclease (New England Biolabs) into fragments ranging in size from 150 to 900 bp, suspended in lysis buffer (150 mM NaCl, 20 mM Tris-HCl, 0.1% SDS, and 0.5%
Triton X-100, pH 8.1) and sonicated with three 10 s pulses. Following preclearance with protein A/G ultralink resin (Thermo Scientific), samples were incubated with 3 µg of anti-NRF-1 antibody (Abcam) overnight with rotation at 4°C. Next, 20 µl of a 50% slurry of blocked protein A/G ultralink resin was added and incubated for 4 hours with rotation at 4°C. Beads were washed with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, and 150 mM NaCl), high-salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM
Tris-HCl, pH 8.1, and 500 mM NaCl), LiCl buffer (0.25 M LiCl, 1% IGEPALCA630, 1% deoxycholic acid, 1mM EDTA, and 10mM Tris, pH 8.1), and TE buffer (10 mM Tris-HCl, pH 8.0, and 1 mM EDTA), in sequence. Complexes were eluted (1% SDS, 0.1 M NaHCO 3 ) at 37°C
for 2 h. NaCl (0.33 M) was added, and cross-linking was reversed by incubation overnight at 65°C. Immunoprecipitated and input DNA were purified with RNase A/proteinase K, recovered by phenol/chloroform extraction, precipitated with ethanol, and resuspended in sterile water.
Real-time qPCR was performed with primers designed to amplify a 240 bp region (-159 to +81) of the mouse TFAM upstream promoter region. Primers were: forward 3'-TAGCCTTGTGGGCTTTCCTG-5' and reverse 5'-TGGTCTAAGGTGGGTGTTGC-3'.
Western blot analysis.
Cells were mechanically removed from tissue culture plates, collected in ice-cold PBS, and centrifuged at 300 × g for 5 min. Pellets were re-suspended in lysis buffer (25 mM Tris-HCl, 150
mM NaCl, and 1% Triton X-100, 2 mM Na3VO4, 1 mM PMSF, with protease inhibitor cocktail, pH 8.0) and protein concentrations were determined using a BCA kit. Homogenates (10-20 µg)
were separated on 7.5% polyacrylamide gels and transferred to PVDF membranes according to standard procedures. A blocking buffer of 5% nonfat powdered milk in TBS with 0.1% Tween 20 was used for all incubations. Membranes were washed, and the ECL Plus Chemiluminescence Kit (GE Healthcare) was used to visualize immunoreactive bands with a Chemi-Doc Imager (Bio-Rad). Primary antibodies were anti-NRF-1 (1:500; Abcam), anti-acetyl-lysine (1:1000; Cell Signaling Technology), anti-CD38 (1:300; Santa Cruz) anti-PGC-1 (1:300; Santa Cruz), anti-β-actin (1:4000; Sigma-Aldrich), and anti-SIRT1 (1:400; Millipore). All antibodies are routinely used in the laboratory and have been extensively validated for use in western blotting.
Densitometry analysis was performed using ImageJ (National Institutes of Health). Values for each lane were normalized to protein loading markers.
Mitochondrial Respiration.
Mitochondrial respiration in cortical neurons was assessed using an XF24 Analyzer (Seahorse Biosciences), as described previously (Roy Chowdhury et al., 2012) . The XF24 creates a transient 7 µl chamber in specialized 24-well microplates that allows for oxygen consumption rate (OCR) to be monitored in real time (Hill et al., 2009) . Neuron density in the range of 50,000-100,000 cells per well gave a linear oxygen consumption rate. Cells were exposed sequentially to oligomycin (1 µM), FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, 1.0-8.0 µM) and rotenone with antimycin A (both 1 µM).
Oligomycin inhibits ATP synthase leading to a build-up of the proton gradient that inhibits electron flux and reveals the state of coupling efficiency. Uncoupling of the respiratory chain by FCCP injection increases OCR to its maximal possible rate and reveals the maximal capacity to reduce oxygen. Finally, rotenone/antimycin A reduces OCR to a baseline by inhibiting the flux of electrons through complexes I and III, and thus no oxygen is further consumed at cytochrome c oxidase. Thus, the remaining oxygen consumption rate after this intervention is primarily nonmitochondrial. Proton leak was determined as the difference between this baseline (nonmitochondrial O 2 consumption) and the nadir caused by oligomycin treatment to eliminate coupled respiration. These principles were used to derive spare respiratory capacity (maximum respiration rate-basal respiration), respiratory control ratio (maximum respiration rate/proton leak), and coupling efficiency (oxidative phosphorylation (OxPhos capacity)/baseline OCR), which is indicative of the relative proportion of basal mitochondrial oxygen consumption that is used for ATP synthesis (Hill et al., 2009; Roy Chowdhury et al., 2012) . Following experiments, cells were immediately fixed and stained for β-tubulin III. Plates were then inserted into a Cellomics ArrayScan-VTI HCS Reader (Thermo Scientific) to determine total neuronal number in each well. Data are expressed as oxygen consumption rate in picomoles per minute per 1000 cells.
Statistical analysis.
All data except qPCR fold-change results were expressed as mean ± SEM. qPCR fold-change results are expressed as the mean ± 95% confidence interval. Statistical analysis was performed throughout using GraphPad Prism version 5.0. One-way ANOVA with Tukey's post hoc test was used to compare multiple normally distributed groups with a single experimental variable.
Differences were considered significant at p<0.05. qPCR fold-change data were log-transformed to fit a normal distribution prior to ANOVA analysis. The number of biological replicates for all experiments are given in the figure legends. No sample size calculation was performed at the beginning of the study. No randomization or blinding was performed in this study.
Results
Genotoxic PARP1 activity compromises mitochondrial respiration
During cellular OCR measurements for a continuous 80 min period, cultures were treated sequentially with oligomycin, followed by FCCP and then rotenone with antimycin A. As depicted in the schematic (Fig. 1A) , this paradigm allows assessment and derivation of several respiratory function parameters, including basal oxygen consumption, spare respiratory capacity, maximal respiratory capacity, coupling efficiency, respiratory control ratio and proton leak.
Cortical neuron cultures were treated with the DNA alkylating agent, MNNG, to cause DNA strand breaks and large-scale activation of PARP1 (Schreiber et al., 1995; Tang et al., 2010) . Cells were exposed to MNNG (50 µM) for 30 min and OCR assessed 1, 2 and 4 hr later (Fig. 1B) . Basal mitochondrial respiration in control neurons was 87.0 ± 4.0 pmol O 2 /min/1000 cells. While there was no significant change 1 hr following MNNG replacement, MNNG reduced basal respiration to 55.1 ± 4.5 pmol O 2 /min/1000 cells by 2 hr (Fig. 1C , F 3,24 = 5.65, p=0.031). The first significant reduction of control maximum respiratory capacity (141.7 ± 8.5
pmol O 2 /min/1000 cells) was also observed 2 hr after MNNG replacement (Fig. 2D, 79 .6 ± 4.3
pmol O 2 /min/1000 cells, F 3,24 = 23.5, p=0.019). By 4 hr, maximum capacity declined to 9.4 ± 2.8
pmol O 2 /min/1000 cells (p<0.020 compared to 2 hr). Similarly, MNN treatment dramatically reduced spare respiratory capacity, causing a decline from 165.0 ± 8.9 to 15.6 ± 4.0% basal rate by 4 hr (Fig. 1E, F 3 ,24 = 23.2, p<0.0001). MNNG had no significant effect on coupling efficiency (Fig. 1F, F 3 ,24 = 2.80, F-test p=0.06 at 4 hr) or proton leak (Fig. 1G, F 3 ,24 = 1.78, F-test p=0.18).
We next tested whether the effects of MNNG on neuronal respiration were mediated by PARP1, using the 4 hr time point. MNNG caused 2.8-fold increase in accumulation of ADPribose polymers (PAR), detected by western blot ( Fig. 2A and B, t 4 = 4.57, p=0.010), indicating production of the PARP1 catalytic product. MNNG effects on basal respiration, maximal respiration, spare capacity and respiratory control ratio were mitigated by genetic deletion of PARP1 ( Fig. 2C-F , parp1 -/-neurons). The effect of PARP inhibitor, PJ34 (10 µM), was slightly less robust, resulting in significant reversal of the MNNG effects only on maximal and spare respiratory capacities ( Fig. 2D and E) . MNNG-induced respiratory dysfunction correlated with reduced neuronal survival, assessed 24 hours after MNNG removal from the culture medium ( Fig. 2G ; 54 ± 13 % survival, F 3,28 = 11.5, p<0.0001). MNNG-induced neuron death was attenuated by PJ34 (78 ± 7% survival, p=0.04 relative to MNNG) and PARP1 deletion (85 ± 8% survival, p=0.002 relative to MNNG). is PARP-dependent (Fig. 3B) . The sirtuin class of histone deacetylases is dependent on NAD + for catalytic activity. We thus examined whether MNNG-induced NAD + depletion is sufficient to interfere with sirtuins. Concomitant with NAD + depletion, sirtuin deacetylase activity declined to 57 ± 6% of control values (F 3,12 = 19.5, p<0.0001), 4 hr following MNNG removal (Fig. 3C ).
Genotoxic
This decline was attenuated by both PJ34 (89 ± 7%, p=0.001 compared to MNNG) and PARP1
deletion (96 ± 14%, p=0.0002 compared to MNNG), indicating sirtuin deacetylase activity is reduced by MNNG in a PARP1-dependent manner.
We hypothesized that MNNG/PARP1-dependent reductions in SIRT1 activity lead to enhanced PGC-1α acetylation and reduced transcription of PGC-1α target genes. SIRT1 is a sirtuin deacetylase reported to suppress activity of the transcription factor PGC-1α by direct interaction (Rodgers et al., 2005) . Using a co-immunoprecipitation approach, SIRT1 was found to be associated with PGC-1α in cortical neuron cultures (Fig. 4A ). Neither MNNG nor using parp1 -/-neurons quantitatively affected binding between SIRT1 and PGC-1α (4 hr), suggesting this relationship is independent of PARP1 activity (Fig. 4B) . In contrast, immunoprecipitation with anti-PGC-1α, followed by immunoblotting for acetyl-lysine residues, revealed significant enhancement of PGC-1α acetylation by MNNG (4 hr; 182 ± 16% control, F 3,8 = 17.6, p=0.0007) in a manner sensitive to attenuation by PJ34 (135 ± 5% control, p=0.021) and PARP1 deletion (112 ± 4% control, p=0.002) (Fig. 4C ). MNNG had no significant effect on total PGC-1α expression levels at the same time point (Fig. 4D , F 3,8 = 0.371, p=0.777).
Mitochondrial gene transcription is limited by PARP1-induced inhibition of PGC-1α
PGC-1α stimulates induction of the nuclear transcription factors, NRF-1 and NRF-2, and serves as a bound co-activator of NRF-1 on the upstream promoter region of TFAM, which is a direct regulator of mitochondrial DNA replication/transcription (Wu et al., 1999) .
Immunoprecipitation of cell homogenates with anti-PGC-1α, followed by immunoblotting with anti-NRF-1, confirmed an interaction between PGC-1α and NRF-1 in cortical neuron cultures (Fig. 5A ) that was significantly suppressed to 57 ± 4% of the control response by MNNG exposure (Fig. 5B, F 3 ,8 = 11.4, p=0.004). The interaction was restored to levels indistinguishable from control by both PJ34 (90 ± 11%, p=065) and PARP1 deletion (98 ± 13%, p=0.99). To determine whether suppression of the PGC-1α/NRF-1 association by MNNG coincides with changes in NRF-1-induced TFAM expression, we isolated nuclear chromatin fragments that bind to NRF-1 using chromatin immunoprecipitation (ChIP), and then used quantitative PCR to amplify a TFAM upstream promoter site (-159 to +81) containing a putative NRF-1 binding sequence. Four hours after MNNG exposure, binding of NRF-1 to the TFAM upstream promoter region was reduced to 32 ± 7% of control (Fig. 5C , F 2,9 = 34.11, p<0.0001). This effect was not observed in the presence of the PARP inhibitor, PJ34 (90 ± 26% control). Quantitative reverse transcriptase PCR showed that TFAM mRNA levels were significantly reduced by MNNG (55 ± 6% control, (F 3,11 = 6.98, p=0.009) in a manner sensitive to both PJ34 (95 ± 29% control) and PARP1 deletion (93 ± 7% control) (Fig. 5D ). Consistent with these findings, the mitochondrial DNA (mtDNA) copy number was reduced to 34 ± 8% of control levels (Fig. 5E , (F 3,11 = 22.9, p<0.0001), and mitochondrial mass was lost (76 ± 6% control; Fig. 5F , (F 3,12 = 15.3, p=0.0002) in response to MNNG. These effects were also dependent on PARP1, as mtDNA and mitochondrial mass changes were not evident in cultures with PJ34 or deletion of PARP1.
Enhancing intracelluar NAD + rescues PARP1-induced declines in mitochondrial gene transcription and respiratory function
PARP1-induced failure of oxidative phosphorylation can be reversed by supplying exogenous Kreb's Cycle substrates or NAD + Ying et al., 2002) . These compounds appear to drive the TCA cycle to overcome PARP1-dependent glycolytic inhibition.
We hypothesized that respiration is also influenced directly by NAD + -dependent transcription of key mitochondrial components. The baseline control NAD + level was 1.4 ± 0.2 nmol/mg protein.
Supplying 3 mM extracellular NAD + mitigated NAD + -depletion 4 hr following MNNG treatment (F 2,9 = 22.3, p=0.024), raising NAD + over baseline to 2.4 ± 0.2 nmol/mg protein (Fig. 6A ).
Exogenous NAD + restored MNNG-induced inhibition of basal respiratory rate from 59.1 ± 9.2% control to 92.3 ± 8.5% control (Fig. 6B, F 2 ,11 = 7.41, p=0.029 compared to MNNG). Maximal respiratory rate was restored from 32 ± 14% to 103 ± 7% control (Fig. 6C , F 2,9 = 10.3, p=0.008 compared to MNNG group), and spare respiratory capacity was restored from 20 ± 12% to 105 ± 7% control (Fig. 6D , F 2,7 = 11.9, p=0.007). In addition, NAD + rescued MNNG-induced impairment of sirtuin deacetylase activity, from 57 ± 3% to 103 ± 2% of control activity (Fig.   6E , F 2,9 = 84.7, p<0.0001), and restored TFAM message (Fig. 6F, F This corresponded with a similar effect on NAD + -dependent sirtuin deacetylase activity (Fig.   7D ). MNNG reduced activity to 54 ± 6% control (F 2,15 = 22.0, p<0.0001) while CD38 loss of function returned it to 93 ± 5% control (p=0.0003, MNNG group; p=0.63, control). Treatment of cultures with CD38 shRNA also reduced MNNG-induced respiratory dysfunction (Fig. 7E) , significantly attenuating declines in basal respiratory rate (Fig. 7F , F 2,8 = 8.36, p=0.08), maximum respiratory capacity (Fig. 7G , F 2,9 = 27.1, p=0.001) and spare respiratory capacity (Fig. 7H , F 2,10 = 55.4, p<0.0001).
SIRT1 gain of function restores mitochondrial respiration inhibited by MNNG
We postulated that pharmacologically driving SIRT1 activity in the presence MNNG could reduce respiratory decline mediated by the SIRT1/PGC-1α signaling axis. Cultures were treated with the SIRT1 activator, SRT1720 (10 µM), after MNNG exposure. An experimental time point was chosen to yield near-half NAD + depletion by MNNG while preserving sufficient residual NAD + to support enhanced SIRT1 activity (1 hr, Fig. 3A) . MNNG reduced NAD + levels from 1.5 ± 0.1 to 0.97 ± 0.03 nmol/mg protein after 1 hr (Fig. 8A, F .0001 compared to MNNG). SRT1720 also significantly restored maximum respiratory capacity inhibited by MNNG (Fig. 8C , F 2,9 = 13.6, p=0.043 compared to MNNG), consistent with reversal of respiratory dysfunction induced by SIRT1/PGC-1α signaling.
Discussion
Our results demonstrate that PARP1 activity reduces NRF-1 activity, TFAM transcription and mitochondrial DNA, with corresponding functional impairment of baseline, maximal and spare respiratory capacities in cortical neuron cultures. PARP1 reduced cellular NAD + levels, inhibited sirtuin deacetylase activity, enhanced acetylation of PGC-1α and mitigated the regulatory interaction between PGC-1α and NRF-1 in a manner restored by exogenous NAD + .
These data support the idea that genotoxic PARP1 activation in neuronal injury leads to NAD + depletion sufficient to inhibit SIRT1 and impair mitochondrial biogenesis by regulating PGC-1α.
Our observation that mitochondrial respiration is impaired by PARP1 activity is underpinned by experiments demonstrating that PARP1 inhibition and deletion mitigates the effects of MNNG. This is consistent with previous studies showing that PARP1 activity inhibits respiration (Alano et al., 2007; Bai et al., 2015; Cañuelo et al., 2012) . PARP1 activity has been shown to cause a progressive decline in the activities of mitochondrial respiratory chain complexes II and IV (Cañuelo et al., 2012) , and reduce basal mitochondrial respiration (Bai et al., 2011) . Our data support inhibition of respiration directly by PARP1-induced NAD + -depletion. NAD + is consumed during ADP-ribosylation to an extent sufficient to inhibit glycolysis (Ying et al., 2003) and limit NADH available for electron transport Ying et al., 2002) . NAD + depletion also contributes to electron transport chain uncoupling and the production of reactive oxygen species by inhibiting individual mitochondrial complexes (Klaidman et al., 2003; Zhou et al., 2006) . In our hands, PARP1 activity depleted total cellular NAD + to about 50% of baseline values by 2 hours after exposure. This likely underestimates the effect on nuclear/cytosolic NAD + pools and the consequences to respiration since our assessment detected both nuclear and mitochondrial NAD + . Importantly, we also found that two separate strategies for NAD + replacement/protection rescued mitochondrial function, supporting an important role of NAD + depletion in inhibition of respiration. Our data do not exclude the possibility that PARP1 can also inhibit respiration by mechanisms independent of NAD + depletion. Free PAR, for example, can directly disrupt mitochondrial function by inhibiting hexokinase (HK) (Andrabi et al., 2014; Fouquerel et al., 2014) and limiting glycolysis. HK also regulates the exchange of ADP/ATP between the cytosol and mitochondria, through a physical association with the outer mitochondrial membrane (Fouquerel et al., 2014) , and therefore couples glycolytic flux with oxidative phosphorylation. Electron transport complexes are also subject to PARylation (Brunyanszki et al., 2016; Cañuelo et al., 2012; Zharova and Vinogradov, 1997) , which may cause further electron transport uncoupling. In addition, PARs can be degraded to ADP-ribose (ADPR) monomers by poly(ADP-ribose) glycohydrolase (Fisher et al., 2007) . Nucleoside diphosphate linked to X pyrophosphatases further hydrolyzes ADPR to AMP, leading to elevated AMP:ATP levels, impaired mitochondrial adenine handling and reduced ATP production (Formentini et al., 2009 ). While we did not assess NAD + independent effects of PARP1-dependent regulation of mitochondrial function, we did observe deficits in cellular OCR that occurred prior to NAD + depletion suggesting that NAD + independent effects may also be involved. Thus our data is in agreement with previous studies and suggests that the role of NAD + in PARP1-dependent regulation of mitochondrial function is time sensitive.
A major focus of the current work was to understand how PARP1-induced NAD + depletion affects gene regulation associated with mitochondrial function. Our data support an important role for NAD + -dependent PGC-1α regulation in PARP1-mediated control of mitochondrial function. PGC-1α directs expression of nuclear-encoded mitochondrial proteins and is therefore an important regulator of mitochondrial biogenesis, structure and function (Mutikainen et al., 2016) . Nuclear transcription factors, such as NRF-1, are downstream targets of PGC-1α that control the expression of key mitochondrial genes required for the replication and transcription of mtDNA (Wu et al., 1999) . Our observation of reduced mitochondrial gene transcription and mass after DNA alkylation sensitive to inhibition by PARP1 loss function led us to postulate that PARP1 influences mitochondrial biosynthesis by regulation PGC-1α. DNA alkylation reduced the physical association between PGC-1α and NRF-1 association, NRF-1 binding to tfam promoter, and TFAM transcription. All of these MNNG-induced effects were mitigated by PARP1 inhibition and deletion. Thus, our results support a PGC-1α-mediated action of PARP1 in cortical neuron cultures.
PGC-1α is extensively regulated by post-translational modification, including acetylation (Dominy et al., 2010) . The NAD + -dependent deacetylase SIRT1 is known to modify PGC-1α and maintain its activity as a transcriptional activator (Mäkelä et al., 2014; Rodgers et al., 2005) .
Furthermore, we and others have shown that uncontrolled PARP1 activity depletes NAD + to levels sufficient to inhibit SIRT1 activity (Bai et al., 2011; Lu et al., 2014 ). Here, we tested whether the PARP1-NAD + -SIRT1 axis is capable of influencing PGC-1α activity and downstream targets of mitochondrial function in neuronal genotoxicity. DNA alkylation caused PARP1-dependent NAD + depletion and reduced sirtuin deacetylase activity with commensurate increases in PGC-1α acetylation and reduced PGC-1α/NRF-1 interaction. Exogenous NAD + supplementation and CD38 loss of function increased intracellular NAD + content and rescued sirtuin deacetylase activity and PGC-1α/NRF-1 associations, as well as deficits in mitochondrial respiration and biogenesis. In addition, SIRT1 gain of function with SRT1720 was able to partially reverse the effects of MNNG on neuronal respiration, suggesting the mitochondrial effects of PARP1 are dependent on SIRT1. Collectively, this is strong evidence that NAD + depletion is an important effector of the SIRT1-PGC-1α signaling axis, activated by pathological PARP1 activity. Our data are consistent with other reports in skeletal and heart muscle linking PARP1 or PARP2 activity with sirtuin and PGC-1α activities (Mohamed et al., 2014; Waldman et al., 2018) , but represent a novel demonstration in neurons.
Our findings support a growing body of evidence that NAD + depletion by PARP1 activity leads to a deleterious sequelae of events. Genotoxic PARP1 activity leads to NAD + depletion that inhibits oxidative phosphorylation and causes excessive ATP consumption, as nicotinamide mononucleotide adenylyltransferase activity attempts to replenish NAD + . There is also evidence that PARP1-dependent NAD + depletion is sufficient to cause mitochondrial permeability transition and cell death dependent on nuclear AIF translocation (Alano et al., 2004) . In addition, we have now demonstrated that neuronal bioenergetics are influenced by PARP1-mediated NAD + depletion in a manner that depends on transcriptional activity. Since SIRT1 affects transcription by modulating many targets, there are other pathways that could contribute to cell damage. Our data show that SIRT1 inhibition leads to hyperacetylation of PGC-1α and reduced mitochondrial respiratory capacity. These findings are consistent with our previous observations that enhanced FoxO3a activity and expression of the pro-death BH 3 -only Bcl-2 family member, Bnip3, result from NAD + depletion and SIRT1 inhibition. Since SIRT1 is a master regulator of many genes that are critical for mitochondrial function, preservation of NAD + levels is likely to have pleiotropic beneficial effects on cell survival. Our work reinforces the idea that maintaining cellular NAD + levels is a promising therapeutic strategy to manage a host of mitochondrial and age-related pathologies (Martens et al., 2018; Srivastava, 2016) . Decreases in transcript levels were mitigated by PJ34 and PARP1 deletion. The same trends were observed for mitochondrial DNA (mtDNA) copy number (E) and mitochondrial mass, assessed by MitoTracker Red fluorescence (F). For B and F: data are means ± SEM (n=3-4); ** p<0.01 compared to wildtype untreated controls and † p<0.05, † † p<0.01 compared to the wildtype MNNG group. Data were analyzed using ANOVA with the Tukey test for multiple comparisons. For C-E: fold-change data are means ± 95% confidence intervals (n=3-4); ** p<0.01 compared to wildtype untreated controls and † p<0.05, † † p<0.01 compared to the wildtype MNNG group. Fold-change data were log-transformed before being analyzed using ANOVA with the Tukey test for multiple comparisons. total mitochondrial DNA (mtDNA) (G) and MitoTracker staining for total mitochondrial mass (H). For C-E and H, data are means ± SEM (n=3-4); * p<0.05, ** p<0.01 compared to wildtype untreated controls and † p<0.05, † † p<0.01 compared to the wildtype MNNG group. Data were analyzed using ANOVA with the Tukey test for multiple comparisons. For F and G, fold-change data are means ± 95% confidence intervals (n=4); ** p<0.01 compared to wildtype untreated controls and † † p<0.01 compared to the wildtype MNNG group. Fold-change data were logtransformed before being analyzed using ANOVA with the Tukey test for multiple comparisons. compared to untreated controls using ANOVA and the Tukey multiple comparison test.
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